Craig R. Skenes
Corporate Officer/Principal at AERIE PHARMACEUTICALS, INC.
Profile
Craig R.
Skenes is currently the Vice President of Business Development at Aerie Pharmaceuticals, Inc. He received his undergraduate degree and MBA from The California State University.
Craig R. Skenes active positions
Companies | Position | Start |
---|---|---|
AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2014-06-15 |
Training of Craig R. Skenes
The California State University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Craig R. Skenes